474 related articles for article (PubMed ID: 26794605)
1. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
[TBL] [Abstract][Full Text] [Related]
2. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
Akdemir G; Heimans L; Bergstra SA; Goekoop RJ; van Oosterhout M; van Groenendael JHLM; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF
Ann Rheum Dis; 2018 Jan; 77(1):111-118. PubMed ID: 28970207
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.
Heimans L; Wevers-de Boer KV; Koudijs KK; Visser K; Goekoop-Ruiterman YP; Harbers JB; Steup-Beekman GM; Lard LR; Grillet BA; Huizinga TW; Allaart CF
Arthritis Res Ther; 2013 Oct; 15(5):R173. PubMed ID: 24517212
[TBL] [Abstract][Full Text] [Related]
5. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.
Akdemir G; Verheul MK; Heimans L; Wevers-de Boer KV; Goekoop-Ruiterman YP; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman GM; Lard LR; Huizinga TW; Trouw LA; Allaart CF
RMD Open; 2016; 2(1):e000172. PubMed ID: 26925251
[TBL] [Abstract][Full Text] [Related]
7. Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.
Wevers-de Boer KV; Heimans L; Visser K; Schouffoer AA; Molenaar ET; van Groenendael JH; Peeters AJ; Speyer I; Collée G; Huizinga TW; Allaart CF
Rheumatology (Oxford); 2015 Aug; 54(8):1380-4. PubMed ID: 25687553
[TBL] [Abstract][Full Text] [Related]
8. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).
Wevers-de Boer K; Visser K; Heimans L; Ronday HK; Molenaar E; Groenendael JH; Peeters AJ; Westedt ML; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2012 Sep; 71(9):1472-7. PubMed ID: 22402145
[TBL] [Abstract][Full Text] [Related]
9. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.
Klarenbeek NB; Güler-Yüksel M; van der Kooij SM; Han KH; Ronday HK; Kerstens PJ; Seys PE; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Jun; 70(6):1039-46. PubMed ID: 21415052
[TBL] [Abstract][Full Text] [Related]
10. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Feb; 73(2):396-400. PubMed ID: 23334213
[TBL] [Abstract][Full Text] [Related]
11. Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis.
Akdemir G; Markusse IM; Bergstra SA; Goekoop RJ; Molenaar ET; van Groenendael JHLM; Kerstens PJSM; Lems WF; Huizinga TWJ; Allaart CF
RMD Open; 2018; 4(1):e000649. PubMed ID: 29862045
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.
Bergstra SA; Landewé RBM; Huizinga TWJ; Allaart CF
Rheumatology (Oxford); 2017 Oct; 56(10):1721-1728. PubMed ID: 28957556
[TBL] [Abstract][Full Text] [Related]
13. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.
van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Güler-Yüksel M; Zwinderman AH; Kerstens PJ; van der Lubbe PA; de Beus WM; Grillet BA; Ronday HK; Huizinga TW; Breedveld FC; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2009 Jun; 68(6):914-21. PubMed ID: 18662933
[TBL] [Abstract][Full Text] [Related]
14. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial.
van Eijk IC; Nielen MM; van der Horst-Bruinsma I; Tijhuis GJ; Boers M; Dijkmans BA; van Schaardenburg D
Rheumatology (Oxford); 2012 Apr; 51(4):686-94. PubMed ID: 22166255
[TBL] [Abstract][Full Text] [Related]
15. BeSt practice: the success of early-targeted treatment in rheumatoid arthritis.
van den Broek M; Lems WF; Allaart CF
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S35-8. PubMed ID: 23078756
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
17. Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning.
Bergstra SA; Olivas O; Akdemir G; Riyazi N; Collée G; van Groenendael JHLM; Landewé RBM; Allaart CF
Arthritis Res Ther; 2017 Sep; 19(1):220. PubMed ID: 28962586
[TBL] [Abstract][Full Text] [Related]
18. The BeSt way of withdrawing biologic agents.
Allaart CF; Lems WF; Huizinga TW
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S14-8. PubMed ID: 24129130
[TBL] [Abstract][Full Text] [Related]
19. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
Smolen JS; Wollenhaupt J; Gomez-Reino JJ; Grassi W; Gaillez C; Poncet C; Le Bars M; Westhovens R
Arthritis Res Ther; 2015 Jun; 17(1):157. PubMed ID: 26063454
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
Allaart CF; Breedveld FC; Dijkmans BA
J Rheumatol Suppl; 2007 Nov; 80():25-33. PubMed ID: 17985420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]